Momenta Asks 1st Circ. To Affirm Enoxaparin Suit Immunity
Momenta Pharmaceuticals Inc. asked the First Circuit Monday to uphold a determination that the company is immune from an antitrust action by Amphastar Pharmaceuticals Inc. over anticoagulant enoxaparin, saying a federal...To view the full article, register now.
Already a subscriber? Click here to view full article